ATOS · Atossa Therapeutics Inc
United States · RS rating 45 · As of 2026-10-14
| Price | 2.78 USD |
|---|---|
| 1-day change | +8.6% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 96 / 89 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 19 / 20 |
| Industry group (rank) | Medical-Services (44) |
| EPS growth Q/Q | +14.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +82.3% |
| Market cap (USD) | $49.3M |